FI74707C
(fi)
*
|
1982-06-29 |
1988-03-10 |
Sandoz Ag |
Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
|
JPS5936675A
(ja)
*
|
1982-07-13 |
1984-02-28 |
サンド・アクチエンゲゼルシヤフト |
二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
|
WO1984003281A1
(en)
*
|
1983-02-19 |
1984-08-30 |
Beecham Group Plc |
Azabicycloalkyl benzamide and anilide derivatives
|
GB8315495D0
(en)
*
|
1983-06-06 |
1983-07-13 |
Sumitomo Chemical Co |
Fungicidal aniline derivatives
|
CH664567A5
(de)
*
|
1983-08-26 |
1988-03-15 |
Sandoz Ag |
Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
|
JPS6084281A
(ja)
*
|
1983-09-14 |
1985-05-13 |
Yoshitomi Pharmaceut Ind Ltd |
3−インド−ルカルボキサミド類
|
US5175173A
(en)
*
|
1983-12-22 |
1992-12-29 |
Sun Jung Hui |
Carboxamides useful as antiemetic or antipsychotic agents
|
US4888353A
(en)
*
|
1986-02-28 |
1989-12-19 |
Erbamont, Inc. |
Carboxamides useful as antiemetic or antipsychotic agents
|
DE3445377A1
(de)
*
|
1983-12-23 |
1985-07-04 |
Sandoz-Patent-GmbH, 7850 Lörrach |
Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
|
US4593034A
(en)
*
|
1984-04-06 |
1986-06-03 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
|
ATE86110T1
(de)
*
|
1984-12-20 |
1993-03-15 |
Sandoz Ag |
Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.
|
CH667657A5
(de)
*
|
1985-01-07 |
1988-10-31 |
Sandoz Ag |
Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
|
US4605652A
(en)
*
|
1985-02-04 |
1986-08-12 |
A. H. Robins Company, Inc. |
Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
|
EP0201165B1
(de)
*
|
1985-03-14 |
1994-07-20 |
Beecham Group Plc |
Arzneimittel zur Behandlung von Emesis
|
GB8623142D0
(en)
*
|
1986-09-26 |
1986-10-29 |
Beecham Group Plc |
Compounds
|
GB8525913D0
(en)
*
|
1985-10-21 |
1985-11-27 |
Beecham Group Plc |
Compounds
|
DE3650772T2
(de)
*
|
1985-04-27 |
2003-04-03 |
F. Hoffmann-La Roche Ag, Basel |
Derivate von Indazole-3-carboxamide und -3-carboxylsäure
|
US4937247A
(en)
*
|
1985-04-27 |
1990-06-26 |
Beecham Group P.L.C. |
1-acyl indazoles
|
GB8511988D0
(en)
*
|
1985-05-11 |
1985-06-19 |
Beecham Group Plc |
Compounds
|
GB8515845D0
(en)
*
|
1985-06-22 |
1985-07-24 |
Beecham Group Plc |
Treatment
|
US5204356A
(en)
*
|
1985-07-24 |
1993-04-20 |
Glaxo Group Limited |
Treatment of anxiety
|
GB8518658D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Medicaments
|
GB8520616D0
(en)
*
|
1985-08-16 |
1985-09-25 |
Beecham Group Plc |
Compounds
|
GB8525844D0
(en)
*
|
1985-10-19 |
1985-11-20 |
Beecham Group Plc |
Compounds
|
DE3687980T2
(de)
*
|
1986-01-07 |
1993-06-17 |
Beecham Group Plc |
Indolderivate mit einer azabicyclischen seitenkette, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zusammensetzungen.
|
EP0235878A3
(de)
*
|
1986-01-16 |
1989-06-14 |
Beecham Group Plc |
Neue Verbindungen
|
US4722834A
(en)
*
|
1986-03-05 |
1988-02-02 |
A. H. Robins Company, Incorporated |
Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs
|
US4717563A
(en)
*
|
1986-03-05 |
1988-01-05 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
|
DE3782107T2
(de)
*
|
1986-07-25 |
1993-04-01 |
Beecham Group Plc |
Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
HU202108B
(en)
*
|
1986-07-30 |
1991-02-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
|
EP0255297B1
(de)
*
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
AT396870B
(de)
*
|
1986-08-07 |
1993-12-27 |
Sandoz Ag |
Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
|
US4772459A
(en)
*
|
1986-09-09 |
1988-09-20 |
Erbamont, Inc. |
Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
|
EP0268309B1
(de)
*
|
1986-09-22 |
1996-12-11 |
Janssen Pharmaceutica N.V. |
Serotonin-Antagonisten zur Behandlung von Wunden
|
US4906755A
(en)
*
|
1986-11-03 |
1990-03-06 |
Merrell Dow Pharmaceuticals Inc. |
Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
|
ZA878096B
(en)
*
|
1986-11-03 |
1988-04-26 |
Merrell Dow Pharmaceuticals Inc. |
Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
|
JP2765845B2
(ja)
*
|
1986-11-21 |
1998-06-18 |
グラクソ、グループ、リミテッド |
中止症候群の予防の治療薬
|
US5198447A
(en)
*
|
1986-11-21 |
1993-03-30 |
Glaxo Group Limited |
Medicaments
|
EP0272052B1
(de)
*
|
1986-12-16 |
1992-07-08 |
A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) |
Angstlösende N-(1-Azabicyclo[2.2.2)oct-3-yl)benzamide und -thiobenzamide
|
IL84845A0
(en)
*
|
1986-12-17 |
1988-06-30 |
Glaxo Group Ltd |
Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
|
US5190954A
(en)
*
|
1986-12-17 |
1993-03-02 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
US5246941A
(en)
|
1986-12-17 |
1993-09-21 |
Glaxo Group Limited |
Method for the treatment of depression
|
US5244909A
(en)
*
|
1986-12-17 |
1993-09-14 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
US4973594A
(en)
*
|
1986-12-17 |
1990-11-27 |
Glaxo Group Limited |
Medicaments
|
US5200414A
(en)
*
|
1986-12-17 |
1993-04-06 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
DE3751404T2
(de)
*
|
1986-12-17 |
1995-12-21 |
Glaxo Group Ltd |
Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen.
|
GB8806990D0
(en)
*
|
1988-03-23 |
1988-04-27 |
Beecham Group Plc |
Novel compounds
|
GB8701022D0
(en)
*
|
1987-01-19 |
1987-02-18 |
Beecham Group Plc |
Treatment
|
DE3852145T2
(de)
*
|
1987-02-18 |
1995-04-06 |
Beecham Group Plc |
Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
|
DE3881950T2
(de)
*
|
1987-04-25 |
1993-09-30 |
Beecham Group Plc |
Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
|
FR2616149B1
(fr)
*
|
1987-06-04 |
1990-10-19 |
Adir |
Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
|
DE3822792C2
(de)
*
|
1987-07-11 |
1997-11-27 |
Sandoz Ag |
Neue Verwendung von 5HT¶3¶-Antagonisten
|
GB8718445D0
(en)
*
|
1987-08-04 |
1987-09-09 |
Wyeth John & Brother Ltd |
Pyridyl-ethers
|
CA1307790C
(en)
*
|
1987-08-04 |
1992-09-22 |
Ian Anthony Cliffe |
Ethers
|
DE3827253A1
(de)
*
|
1987-08-20 |
1989-03-02 |
Sandoz Ag |
Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
|
GB8720805D0
(en)
*
|
1987-09-04 |
1987-10-14 |
Naylor R J |
2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
|
US4921982A
(en)
*
|
1988-07-21 |
1990-05-01 |
Eli Lilly And Company |
5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT3 antagonists
|
US5364863A
(en)
*
|
1987-09-08 |
1994-11-15 |
Eli Lilly And Company |
Specific 5-HT3 antagonists
|
GB8723157D0
(en)
*
|
1987-10-02 |
1987-11-04 |
Beecham Group Plc |
Compounds
|
EP0311724A1
(de)
*
|
1987-10-16 |
1989-04-19 |
Synthelabo |
Anxiolytische R-N-(1-Azabicyclo[2.2.2]oct-3-yl)-benzamide und -thiobenzamide
|
CA1304082C
(en)
*
|
1987-10-22 |
1992-06-23 |
Tetsuya Tahara |
Benzoxazine compounds and pharmaceutical use thereof
|
NZ227229A
(en)
*
|
1987-12-10 |
1991-03-26 |
Duphar Int Res |
Indole derivatives and pharmaceutical compositions
|
US4863919A
(en)
*
|
1988-02-01 |
1989-09-05 |
A. H. Robins Company, Incorporated |
Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
|
ES2080727T3
(es)
*
|
1988-02-23 |
1996-02-16 |
Merrell Pharma Inc |
Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos.
|
IT1226389B
(it)
*
|
1988-07-12 |
1991-01-15 |
Angeli Inst Spa |
Nuovi derivati ammidinici e guanidinici
|
US5017573A
(en)
*
|
1988-07-29 |
1991-05-21 |
Dainippon Pharmaceutical Co., Ltd. |
Indazole-3-carboxylic acid derivatives
|
US5166341A
(en)
*
|
1988-07-29 |
1992-11-24 |
Dainippon Pharmaceutical Co., Ltd. |
6-amino-1,4-hexahydro-1H-diazepine derivatives
|
DE3878235T2
(de)
*
|
1988-08-04 |
1993-06-03 |
Synthelabo |
Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
|
CA2004911A1
(en)
*
|
1988-12-22 |
1990-06-22 |
Mitsuaki Ohta |
4,5,6,7-tetrahydrobenzimidazole derivatives
|
ATE144511T1
(de)
*
|
1989-02-02 |
1996-11-15 |
Yamanouchi Pharma Co Ltd |
Tetrahydrobenzimidazol-derivate
|
GB8904551D0
(en)
*
|
1989-02-28 |
1989-04-12 |
Glaxo Group Ltd |
Chemical compounds
|
US4914207A
(en)
*
|
1989-05-09 |
1990-04-03 |
Pfizer Inc. |
Arylthiazolylimidazoles
|
GB8913646D0
(en)
*
|
1989-06-14 |
1989-08-02 |
Glaxo Group Ltd |
Chemical compounds
|
US5126343A
(en)
*
|
1989-09-11 |
1992-06-30 |
G. D. Searle & Co. |
N-azabicyclo [3.3.0]octane amides of aromatic acids
|
US5225419A
(en)
*
|
1989-10-14 |
1993-07-06 |
John Wyeth & Brother, Limited |
Certain 1,8-ethano or propano-1,4-dihydro-4-oxo-quinoline-3-carboxamides and derivatives thereof
|
GB2236751B
(en)
|
1989-10-14 |
1993-04-28 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
US5446050A
(en)
*
|
1989-11-17 |
1995-08-29 |
Pfizer Inc. |
Azabicyclo amides and esters as 5-HT3 receptor antagonists
|
CA2030051C
(en)
*
|
1989-11-17 |
2001-08-07 |
Haruhiko Kikuchi |
Indole derivatives
|
GB8928837D0
(en)
*
|
1989-12-21 |
1990-02-28 |
Beecham Group Plc |
Pharmaceuticals
|
US5140023A
(en)
*
|
1990-04-27 |
1992-08-18 |
G. D. Searle & Co. |
Azatetracycle compounds
|
GB9009542D0
(en)
*
|
1990-04-27 |
1990-06-20 |
Beecham Group Plc |
Novel compounds
|
US5223613A
(en)
*
|
1990-04-27 |
1993-06-29 |
G. D. Searle & Co. |
Azatetracycle compounds and process of preparing same
|
US5187166A
(en)
*
|
1990-07-31 |
1993-02-16 |
Nisshin Flour Milling Co., Ltd. |
Azabicyclo derivatives and their use as antiemetics
|
US5189041A
(en)
*
|
1990-11-16 |
1993-02-23 |
Syntex (U.S.A.) Inc. |
Tricyclic 5-ht3 receptor antagonists
|
AU9102991A
(en)
*
|
1990-11-29 |
1992-06-25 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
2,6-methano-2h-1-benzoxocincarboxamides as 5-ht3-antagonists
|
JP3026845B2
(ja)
*
|
1991-02-20 |
2000-03-27 |
日清製粉株式会社 |
ピペリジン誘導体
|
US5227377A
(en)
*
|
1991-03-07 |
1993-07-13 |
G. D. Searle & Co. |
Meso-azacyclic amides of certain bicyclic carboxylic acids
|
AU1578692A
(en)
*
|
1991-03-07 |
1992-10-06 |
G.D. Searle & Co. |
New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
|
US5260303A
(en)
*
|
1991-03-07 |
1993-11-09 |
G. D. Searle & Co. |
Imidazopyridines as serotonergic 5-HT3 antagonists
|
US5219850A
(en)
*
|
1991-03-07 |
1993-06-15 |
G. D. Searle & Co. |
Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
|
US5137893A
(en)
*
|
1991-03-07 |
1992-08-11 |
G. D. Searle & Co. |
Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
|
US5234921A
(en)
*
|
1991-03-07 |
1993-08-10 |
G. D. Searle & Co. |
Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals
|
US5196547A
(en)
*
|
1991-03-07 |
1993-03-23 |
G. D. Searle & Co. |
Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
|
US5516782A
(en)
*
|
1991-03-07 |
1996-05-14 |
G. D. Searle & Co. |
New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
|
CA2116024A1
(en)
*
|
1991-08-20 |
1993-03-04 |
Francis David King |
5-ht4 receptor antagonists
|
JPH06510764A
(ja)
*
|
1991-09-12 |
1994-12-01 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
5−ht4レセプター・アンタゴニスト用のアザ二環式化合物
|
US5344831A
(en)
*
|
1992-01-31 |
1994-09-06 |
Nisshin Flour Milling Co., Ltd. |
Diazabicyclo derivatives
|
JP2699794B2
(ja)
*
|
1992-03-12 |
1998-01-19 |
三菱化学株式会社 |
チエノ〔3,2−b〕ピリジン誘導体
|
US5852014A
(en)
*
|
1992-03-12 |
1998-12-22 |
Smithkline Beecham P.L.C. |
Condensed indole derivatives as 5HT4 -receptor antagonists
|
JPH05310732A
(ja)
*
|
1992-03-12 |
1993-11-22 |
Mitsubishi Kasei Corp |
シンノリン−3−カルボン酸誘導体
|
US5236931A
(en)
*
|
1992-03-26 |
1993-08-17 |
A. H. Robins Company, Incorporated |
2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
|
US5748825A
(en)
*
|
1992-08-03 |
1998-05-05 |
Rockwell, Iii; Marshall A. |
Liquid crystal optical waveguide display system
|
GR1001378B
(el)
*
|
1992-10-08 |
1993-10-29 |
Smithkline Beecham Plc |
Ανταγωνιστές 5-ΗΤ4 πιπεριδυλαλκυλίου.
|
ES2056728B1
(es)
*
|
1992-10-28 |
1995-05-01 |
Smithkline Beecham Plc |
Nuevos derivados de piperidilo y aminoalquilo con actividad antagonista del receptor 5-ht4
|
GB9414900D0
(en)
*
|
1994-07-23 |
1994-09-14 |
Smithkline Beecham Plc |
Novel process
|
US5723103A
(en)
*
|
1994-12-09 |
1998-03-03 |
Vanderbilt University |
Substituted benzamides and radioligand analogs and methods of use
|
WO2000044743A1
(fr)
*
|
1999-01-28 |
2000-08-03 |
Nippon Shinyaku Co., Ltd. |
Derives d'amides et compositions de medicaments
|
KR20010112673A
(ko)
*
|
2000-06-09 |
2001-12-21 |
김환기 |
트로피세트론 염산염(일반식ⅰ)의 제조방법
|
WO2002016357A2
(en)
|
2000-08-18 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
|
US6492385B2
(en)
|
2000-08-18 |
2002-12-10 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
US6479510B2
(en)
|
2000-08-18 |
2002-11-12 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
US6599916B2
(en)
|
2000-08-21 |
2003-07-29 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
WO2002017358A2
(en)
|
2000-08-21 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
|
AR036040A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
|
AR036041A1
(es)
*
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
AUPR701101A0
(en)
*
|
2001-08-14 |
2001-09-06 |
Commonwealth Scientific And Industrial Research Organisation |
Agonists and antagonists of 5ht3-like receptors of invertebrates as pesticides
|
EP1419162A1
(de)
*
|
2001-08-24 |
2004-05-19 |
Pharmacia & Upjohn Company |
Substituierte aryl-7-aza 2,2,1 bicycloheptane zur behandlung von krankheiten
|
US20030105089A1
(en)
*
|
2001-09-12 |
2003-06-05 |
Wishka Donn G. |
Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
|
GEP20063814B
(en)
|
2001-10-02 |
2006-05-10 |
Upjohn Co |
Azabicyclic-Substituted Fused-Heteroaryl Compounds for Treatment of DiseaseAzabicyclic-Substituted Fused-Heteroaryl Compounds for Treatment of Disease
|
US6849620B2
(en)
|
2001-10-26 |
2005-02-01 |
Pfizer Inc |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
|
EP1476151B1
(de)
*
|
2002-02-12 |
2008-07-16 |
N.V. Organon |
1-arylsulfonyl-3-substituierte indol und indolinederivate verwendbar zur behandlung von erkrankungen des zentralnervensystem
|
BR0307714A
(pt)
|
2002-02-15 |
2005-02-09 |
Upjohn Co |
Benzoilamidas substituìdas com azabiciclo e tioamidas para tratamento de distúrbios relacionados ao cns
|
US6858613B2
(en)
*
|
2002-02-19 |
2005-02-22 |
Pfizer Inc. |
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
|
US6894042B2
(en)
*
|
2002-02-19 |
2005-05-17 |
Pharmacia & Upjohn Company |
Azabicyclic compounds for the treatment of disease
|
US7001900B2
(en)
*
|
2002-02-20 |
2006-02-21 |
Pfizer Inc. |
Azabicyclic compounds for the treatment of disease
|
EP1542999A1
(de)
|
2002-08-01 |
2005-06-22 |
Pharmacia & Upjohn Company LLC |
1h-pyrazol- und 1h-pyrrol-azabicyclische verbindungen mit alpha-7-nachr-aktivität
|
US7429664B2
(en)
|
2002-09-25 |
2008-09-30 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
AU2003269401A1
(en)
*
|
2002-11-01 |
2004-05-25 |
Pharmacia & Upjohn Company Llc |
Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases
|
CA2523718A1
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
NZ548228A
(en)
|
2003-12-22 |
2009-04-30 |
Memory Pharm Corp |
Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
DE602005024677D1
(de)
|
2004-04-22 |
2010-12-23 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
|
KR20070015607A
(ko)
*
|
2004-05-07 |
2007-02-05 |
메모리 파마슈티칼스 코포레이션 |
1h-인다졸, 벤조티아졸, 1,2-벤조이속사졸,1,2-벤조이소티아졸, 및 크로몬 및 그의 제조법 및 용도
|
CN100390172C
(zh)
*
|
2004-09-10 |
2008-05-28 |
成都欣捷高新技术开发有限公司 |
一种甲磺酸多拉司琼晶型及其制备方法
|
EP1814869A2
(de)
|
2004-11-18 |
2007-08-08 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituierte aminosäuren als protein-tyrosin-phosphatasehemmer
|
ATE455776T1
(de)
|
2004-12-22 |
2010-02-15 |
Memory Pharm Corp |
Nikotinische alpha-7-rezeptorliganden gegen erkrankungen des zns
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
JP5955767B2
(ja)
|
2009-05-20 |
2016-07-20 |
インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) |
損傷性前庭障害の処置における使用のためのセロトニン5−ht3受容体拮抗薬
|
EP2253316B1
(de)
|
2009-05-20 |
2013-08-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serotonin-5-HT3-Rezeptorantagonisten zur Verwendung bei der Behandlung oder Prävention einer Innenohr-Pathologie mit Vestibularisdefiziten
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
HUE055175T2
(hu)
|
2014-09-29 |
2021-11-29 |
Takeda Pharmaceuticals Co |
Az 1-(1-metil-1H-pirazol-4-il)-N-((1R,5S,7S)-9-metil-3-oxa-9-azabiciklo[3.3.1] nonan-7-il)-1H-indol-3-karboxamid kristályos formája
|
RU2681931C2
(ru)
*
|
2017-08-01 |
2019-03-14 |
Фарид Шамилевич Шагиахметов |
Фармацевтическая комбинация для лечения алкогольной зависимости
|